Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis

Toxicology in Vitro

Volumn 25, Issue 5, 2011, Pages 1007-1017

  Huovinen, Marjo ^a   Loikkanen, Jarkko ^a   Myllynen, Päivi ^b   Vähäkangas, Kirsi H ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Benzo(a)pyrene; BPDE DNA adducts; Cell viability; P53 Phosphorylation; TP53 mutation

Indexed keywords

BENZO[A]PYRENE; DIHYDROXYBENZO[A]PYRENE OXIDE; PROTEIN P53; SERINE;

ARTICLE; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CARCINOGEN DNA INTERACTION; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CHEMICAL CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXON; GENE MUTATION; GENOTOXICITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; APOPTOSIS; BENZO(A)PYRENE; CARCINOGENS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOBLOTTING; MUTATION; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79957950995     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.03.018     Document Type: Article

References (58)

1. Anand P., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., Lai O.S., Sung B., Aggarwal B.B. Cancer is preventable disease that requires major lifestyle changes. Pharm. Res. 2008, 25:2097-2116.
2. Bode A.M., Dong Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 2004, 4:793-805.
3. Brazda V., Muller P., Brozkova K., Vojtesek B. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity. Biochem. Biophys. Res. Commun. 2006, 351:499-506.
4. Brody J.G., Rudel R.A., Michels K.B., Moysich K.B., Bernstein L., Attfield K.R., Gray S. Environmental pollutants, diet, physical activity, body size and breast cancer: Where do we stand in research to identify opportunities for prevention?. Cancer 2007, 109(12 Suppl):2627-2634.
5. Brody J.G., Moysich K.B., Humblet O., Attfield K.R., Beehler G.P., Rudel R.A. Environmental pollutants and breast cancer: epidemiologic studies. Cancer 2007, 109(12 Suppl):2667-2711.
6. Brody, J.G., Rudel, R.A., 2008. Environmental pollutants and breast cancer: the evidence from animal and human studies. Breast Diseases: A Year Book® Quarterly 19, 17-19.
7. Cailleau R., Young R., Olivé M., Reeves W.J. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 1974, 53:661-674.
8. Cailleau R., Olivé M., Cruciger Q.V.J. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978, 14:911-915.
9. Castano-Vinyals G., D'Errico A., Malats N., Kogevinas M. Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occup. Environ. Med. 2004, 61:e12.
10. Chen Y., Chen P.-L., Lee W.-H. Hot-Spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle. Mol. Cell. Biol. 1994, 14:6764-6772.
11. Engel L.W., Young N.A., Tralka T.S., Lippman M.E., O'Brien S.J., Joyce M.J. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 1978, 38:3352-3364.
12. Gelboin H.V. Benzo(a)pyrene metabolism activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 1980, 4:1107-1166.
13. Gillotin S., Yap D., Lu X. Mutation at Ser392 specifically sensitizes mutant p53H175 to mdm2-mediated degradation. Cell Cycle 2010, 9:1390-1398.
14. Guimaraes D.P., Hainaut P. TP53: a key gene in human cancer. Biochimie 2002, 84:83-93.
15. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
16. Hainaut P., Vähäkangas K. P53 as a sensor of carcinogenic exposures: mechanism of p53 protein induction and lessons from p53 gene mutations. Path. Biol. 1997, 45:833-844.
17. Hakkarainen J., Welsh J.A., Vähäkangas K.H. TP53 Mutation detection by SSCP and sequencing. Methods Mol. Med. 2004, 97:191-208.
18. Högberg J., Silins I., Stenius U. Chemical induced alterations in p53 signaling. EXS 2009, 99:181-208.
19. IARC Monographs on the evaluation of carcinogenic risks to humans: some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures, vol. 92, 2010.
20. Keller D.M., Zeng X., Wang Y., Zhang Q.H., Kapoor M., Shu H., Goodman R., Lozano G., Zhao Y., Lu H. A DNA Damage-Induced p53 Serine 392 Kinase Complex Contains CK2, hSpt16, and SSRP1. Mol. Cell 2001, 7:283-292.
21. Keydar I., Chen L., Karby S., Weiss F.R., Delarea J., Radu M., Chaitcik S., Brenner H.J. Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 1979, 15:659-670.
22. Lai J., Myers S.A., Lawrence M.G., Odorico D.M., Clements J.A. Direct progesterone receptor and indirect androgen receptor interactions with the Kallikrein-related peptidase 4 gene promoter in breast and prostate cancer. Mol. Cancer Res. 2009, 7:129-141.
23. Lane D.P. P53, guardian of the genome. Nature 1992, 358:15-16.
24. Lavin M.F., Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 2006, 13:941-950.
25. Li M., Luo J., Brooks C.L., Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 2002, 277:50607-50611.
26. Loikkanen J., Chvalova K., Naarala J., Vähäkangas K.H., Savolainen K.M. Pb2+ induced toxicity is associated with p53-independent apoptosis and enhanced by glutamate in GT1-7 neurons. Toxicol. Lett. 2003, 144:235-246.
27. Lu M., Mira-y-Lopez R., Nakajo S., Nakaya K., Jing Y. Expression of estrogen receptor α, retinoic acid receptor α and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells. Oncogene 2005, 24:4362-4369.
28. Matsumoto M., Furihata M., Ohtsuki Y. Post-translational phosphorylation of mutant p53 protein in tumor development. Med. Mol. Morphol. 2006, 39:79-87.
29. Meek D.W., Anderson C.W. Post-translational modification of p53: cooperative integrators of function. Cold Spring Harbor Perspect. Biol. 2009, 1(6):a000950. Epub 2009 Oct 28.
30. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. P53 Has a Direct Apoptogenic Role at the Mitochondria. Mol. Cell 2003, 11:577-590.
31. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. P53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46 phosphorylated p53. Cell 2000, 102:849-862.
32. Park D.J., Nakamura H., Chumakov A.M., Said J.W., Miller C.W., Chen D.L., Koeffler H.P. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene 1994, 9:1899-1906.
33. Pelkonen O., Vähäkangas K. Metabolic activation and inactivation of chemical carcinogens. J. Toxicol. Environ. Health 1980, 6:989-999.
34. Peltonen J.K., Helppi H.M., Pääkkö P., Turpeenniemi-Hujanen T., Vähäkangas K.H. P53 in head and neck cancer: functional consequences and environmental implications of TP53 mutations. Head Neck Oncol. 2010, 2:36.
35. Petitjean A., Mathe E., Kato S., Ishioka C., Tavtigian S.V., Hainaut P., Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 2007, 28:622-629. (IARC database R14, November 2009).
36. Roy A.M., Baliga M.S., Katiyar S.K. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol. Cancer Ther. 2005, 4:81-90.
37. Rämet M., Castrén K., Järvinen K., Pekkala K., Turpeenniemi-Hujanen T., Soini Y., Pääkkö P., Vähäkangas K. P53 protein expression is correlated with benzo(a)pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis 1995, 16:2117-2124.
38. Rudel R.A., Attfield K.R., Schifano J.N., Brody J.G. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer 2007, 109(12 Suppl):2635-2666.
39. Sadikovic B., Rodenhiser D.I. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells. Tox. Appl. Pharm. 2006, 216:458-468.
40. Sakaguchi K., Sakamoto H., Lewis M.S., Anderson C.W., Erickson J.W., Appella E., Xie D. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 1997, 36:10117-10124.
41. Sarafian T.A., Vartavarian L., Kane D.J., Bredesen D.E., Verity M.A. Bcl-2 expression decreases methyl mercury-induced free-radical generation and cell killing in a neural cell line. Toxicol. Lett. 1994, 74:149-155.
42. Soule H.D., Vazguez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 1973, 51:1409-1416.
43. Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol. 2010, 20:14-24.
44. Spink D.C., Spink B.C., Cao J.Q., DePasquale J.A., Pentecost B.T., Fasco M.J., Li Y., Sutter T.R. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 1998, 19:291-298.
45. Spink B.C., Pang S., Pentecost B.T., Spink D.C. Induction of cytochrome P450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls. Toxicol. Vit. 2002, 16:695-704.
46. Spink D.C., Wu S.J., Spink B.C., Hussain M.M., Vakharia D.D., Pentecost B.T., Kaminsky L.S. Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast cancer cells: roles of PAH interactions and PAH metabolites. Toxicol. Appl. Pharmacol. 2008, 226:213-224.
47. Tampio M., Loikkanen J., Myllynen P., Mertanen A., Vähäkangas K.H. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells. Toxicol Lett. 2008, 178:152-159.
48. Tampio M., Markkanen P., Puttonen K.A., Hagelberg E., Heikkinen H., Huhtinen K., Loikkanen J., Hirvonen M.-R., Vähäkangas K.H. Induction of PUMA-alpha and down-regulation of PUMA-beta expression is associated with benzo(a)pyrene-induced apoptosis in MCF-7 cells. Toxicol. Lett. 2009, 188:214-222.
49. Tomita Y., Marchenko N., Erster S., Nemajerova A., Dehner A., Klein C., Pan H., Kessler H., Pancoska P., Moll U.M. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J. Biol. Chem. 2006, 281:8600-8606.
50. Troester M.A., Herschkowitz J.I., Oh D.S., He X., Hoadley K.A., Barbier C.S., Perou C.M. Gene expression patterns associated with p53 status in breast cancer. BMC Cancer 2006, 6:276.
51. Tsai K.S., Yang R.S., Liu S.H. Benzo(a)pyrene regulates osteoblast proliferation through an estrogen receptor-related cyclooxygenase-2 pathway. Chem. Res. Toxicol. 2004, 17:679-684.
52. Vousden K., Lane D.P. P53 in health and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:275-283.
53. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer. 2002, 2:594-604.
54. Vähäkangas K., Haugen A., Harris C.C. An applied synchronous fluorescence spectrophotometric assay to study benzo(a)pyrene-diolepoxide-DNA adducts. Carcinogenesis 1985, 6:1109-1115.
55. Wang W., Smith R., Burghardt R., Safe S.H. 17β-Estradiol-mediated growth inhibition of MDA-MB-468 cells stably transfected with the estrogen receptor: cell cycle effects. Mol. Cell Endocrinol. 1997, 133:49-62.
56. Wang W.L., Porter W., Burghardt R., Safe S.H. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 1997, 18:925-933.
57. Xue W., Warshawsky D. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol. Appl. Pharmacol. 2005, 206:73-93.
58. Yoshida K., Liu H., Miki Y. Protein kinase C δ regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J. Biol. Chem. 2006, 281:5734-5740.